paragraph_index int64 | sec string | p_has_citation int64 | cites string | citeids list | pmid int64 | cited_id string | sentences string | all_sent_cites list | sent_len int64 | sentence_batch_index int64 | sent_has_citation float64 | qc_fail bool | cited_sentence string | cites_in_sentence list | cln_sentence string | is_cap bool | is_alpha bool | ends_wp bool | cit_qc bool | lgtm bool | __index_level_0__ int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | DISCUSSION | 1 | 1 | [
"r1",
"r41",
"r42",
"r22",
"r5",
"r6",
"r35",
"r20",
"r21",
"r3",
"r20",
"r21",
"r43",
"r44"
] | 18,443,205 | pmid-16186396|pmid-9832430|pmid-17141630|pmid-17227768|pmid-16823477|pmid-12606524|pmid-16505240|pmid-12021247|pmid-11489937|pmid-11533494|pmid-12021247|pmid-11489937|pmid-17959861|pmid-17317777 | Although the role of TNF-α in the development of skeletal muscle insulin resistance in type 2 diabetic patients remains unresolved, current evidence suggests that IKKβ may be an intermediate kinase through which TNF-α and other inflammatory processes induce skeletal muscle insulin resistance (5,6,35). | [
"1",
"41",
"42",
"22",
"5",
"6",
"35",
"20",
"21",
"3",
"20",
"21",
"43",
"44"
] | 302 | 42,719 | 0 | false | Although the role of TNF-α in the development of skeletal muscle insulin resistance in type 2 diabetic patients remains unresolved, current evidence suggests that IKKβ may be an intermediate kinase through which TNF-α and other inflammatory processes induce skeletal muscle insulin resistance. | [
"5,6,35"
] | Although the role of TNF-α in the development of skeletal muscle insulin resistance in type 2 diabetic patients remains unresolved, current evidence suggests that IKKβ may be an intermediate kinase through which TNF-α and other inflammatory processes induce skeletal muscle insulin resistance. | true | true | true | true | true | 7,403 |
2 | DISCUSSION | 1 | 1 | [
"r1",
"r41",
"r42",
"r22",
"r5",
"r6",
"r35",
"r20",
"r21",
"r3",
"r20",
"r21",
"r43",
"r44"
] | 18,443,205 | pmid-16186396|pmid-9832430|pmid-17141630|pmid-17227768|pmid-16823477|pmid-12606524|pmid-16505240|pmid-12021247|pmid-11489937|pmid-11533494|pmid-12021247|pmid-11489937|pmid-17959861|pmid-17317777 | IKKβ activation has been closely linked to the development and pathogenesis of insulin resistance (20,21). | [
"1",
"41",
"42",
"22",
"5",
"6",
"35",
"20",
"21",
"3",
"20",
"21",
"43",
"44"
] | 106 | 42,720 | 0 | false | IKKβ activation has been closely linked to the development and pathogenesis of insulin resistance. | [
"20,21"
] | IKKβ activation has been closely linked to the development and pathogenesis of insulin resistance. | true | true | true | true | true | 7,403 |
2 | DISCUSSION | 1 | 43 | [
"r1",
"r41",
"r42",
"r22",
"r5",
"r6",
"r35",
"r20",
"r21",
"r3",
"r20",
"r21",
"r43",
"r44"
] | 18,443,205 | pmid-16186396|pmid-9832430|pmid-17141630|pmid-17227768|pmid-16823477|pmid-12606524|pmid-16505240|pmid-12021247|pmid-11489937|pmid-11533494|pmid-12021247|pmid-11489937|pmid-17959861|pmid-17317777 | Pharmacological inhibition of IKKβ activity improves insulin-mediated glucose metabolism (3,20,21), even in insulin-resistant obese, nondiabetic individuals (43). | [
"1",
"41",
"42",
"22",
"5",
"6",
"35",
"20",
"21",
"3",
"20",
"21",
"43",
"44"
] | 162 | 42,721 | 1 | false | Pharmacological inhibition of IKKβ activity improves insulin-mediated glucose metabolism, even in insulin-resistant obese, nondiabetic individuals. | [
"3,20,21",
"43"
] | Pharmacological inhibition of IKKβ activity improves insulin-mediated glucose metabolism, even in insulin-resistant obese, nondiabetic individuals. | true | true | true | true | true | 7,403 |
2 | DISCUSSION | 1 | 44 | [
"r1",
"r41",
"r42",
"r22",
"r5",
"r6",
"r35",
"r20",
"r21",
"r3",
"r20",
"r21",
"r43",
"r44"
] | 18,443,205 | pmid-16186396|pmid-9832430|pmid-17141630|pmid-17227768|pmid-16823477|pmid-12606524|pmid-16505240|pmid-12021247|pmid-11489937|pmid-11533494|pmid-12021247|pmid-11489937|pmid-17959861|pmid-17317777 | Increased expression of IKKβ has been noted in omental fat from obese humans, potentially contributing to differential roles of omental and subcutaneous fat in the pathophysiology of obesity (44). | [
"1",
"41",
"42",
"22",
"5",
"6",
"35",
"20",
"21",
"3",
"20",
"21",
"43",
"44"
] | 196 | 42,722 | 1 | false | Increased expression of IKKβ has been noted in omental fat from obese humans, potentially contributing to differential roles of omental and subcutaneous fat in the pathophysiology of obesity. | [
"44"
] | Increased expression of IKKβ has been noted in omental fat from obese humans, potentially contributing to differential roles of omental and subcutaneous fat in the pathophysiology of obesity. | true | true | true | true | true | 7,403 |
3 | DISCUSSION | 1 | 45 | [
"r45",
"r3",
"r46"
] | 18,443,205 | pmid-15351728|pmid-11533494|pmid-14755344 | Studies linking IKKβ and skeletal muscle insulin resistance in rodents have yielded conflicting results. | [
"45",
"3",
"46"
] | 104 | 42,723 | 0 | false | Studies linking IKKβ and skeletal muscle insulin resistance in rodents have yielded conflicting results. | [] | Studies linking IKKβ and skeletal muscle insulin resistance in rodents have yielded conflicting results. | true | true | true | true | true | 7,404 |
3 | DISCUSSION | 1 | 45 | [
"r45",
"r3",
"r46"
] | 18,443,205 | pmid-15351728|pmid-11533494|pmid-14755344 | Pharmacological IKKβ inhibition ameliorated insulin resistance and upregulated plasma levels of adiponectin in KKAy mice fed a high-fat diet (45). | [
"45",
"3",
"46"
] | 146 | 42,724 | 1 | false | Pharmacological IKKβ inhibition ameliorated insulin resistance and upregulated plasma levels of adiponectin in KKAy mice fed a high-fat diet. | [
"45"
] | Pharmacological IKKβ inhibition ameliorated insulin resistance and upregulated plasma levels of adiponectin in KKAy mice fed a high-fat diet. | true | true | true | true | true | 7,404 |
3 | DISCUSSION | 1 | 3 | [
"r45",
"r3",
"r46"
] | 18,443,205 | pmid-15351728|pmid-11533494|pmid-14755344 | Heterozygous IKKβ+/− mice fed a high-fat diet or intergressed on an obese ob/ob mice background were protected against the development of insulin resistance (3). | [
"45",
"3",
"46"
] | 161 | 42,725 | 1 | false | Heterozygous IKKβ+/− mice fed a high-fat diet or intergressed on an obese ob/ob mice background were protected against the development of insulin resistance. | [
"3"
] | Heterozygous IKKβ+/− mice fed a high-fat diet or intergressed on an obese ob/ob mice background were protected against the development of insulin resistance. | true | true | true | true | true | 7,404 |
3 | DISCUSSION | 1 | 46 | [
"r45",
"r3",
"r46"
] | 18,443,205 | pmid-15351728|pmid-11533494|pmid-14755344 | Conversely, mice with either skeletal muscle–specific IKKβ knockout or a separate cohort of heterozygous IKKβ+/− were not protected against gold thioglucose–induced obesity or dietary-induced metabolic abnormalities (46). | [
"45",
"3",
"46"
] | 221 | 42,726 | 1 | false | Conversely, mice with either skeletal muscle–specific IKKβ knockout or a separate cohort of heterozygous IKKβ+/− were not protected against gold thioglucose–induced obesity or dietary-induced metabolic abnormalities. | [
"46"
] | Conversely, mice with either skeletal muscle–specific IKKβ knockout or a separate cohort of heterozygous IKKβ+/− were not protected against gold thioglucose–induced obesity or dietary-induced metabolic abnormalities. | true | true | true | true | true | 7,404 |
3 | DISCUSSION | 1 | 45 | [
"r45",
"r3",
"r46"
] | 18,443,205 | pmid-15351728|pmid-11533494|pmid-14755344 | The reason for the differences noted between these animal models is unknown, but the differences could be strain specific or related to undefined experimental differences. | [
"45",
"3",
"46"
] | 171 | 42,727 | 0 | false | The reason for the differences noted between these animal models is unknown, but the differences could be strain specific or related to undefined experimental differences. | [] | The reason for the differences noted between these animal models is unknown, but the differences could be strain specific or related to undefined experimental differences. | true | true | true | true | true | 7,404 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | TNF-α exposure leads to activation of two separate transcription factor–signaling pathways, namely the IKKβ and JNK pathways, which are linked to proinflammatory responses associated with obesity and insulin resistance (47). | [
"47",
"25",
"26",
"48"
] | 224 | 42,728 | 1 | false | TNF-α exposure leads to activation of two separate transcription factor–signaling pathways, namely the IKKβ and JNK pathways, which are linked to proinflammatory responses associated with obesity and insulin resistance. | [
"47"
] | TNF-α exposure leads to activation of two separate transcription factor–signaling pathways, namely the IKKβ and JNK pathways, which are linked to proinflammatory responses associated with obesity and insulin resistance. | true | true | true | true | true | 7,405 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | Here, we show that siRNA-mediated gene silencing of IKKβ prevented TNF-α–induced insulin resistance on glucose uptake and metabolism in cultured myotubes, with a concomitant increase in phosphorylation of Akt (at Ser473, Thr308), and AS160. | [
"47",
"25",
"26",
"48"
] | 240 | 42,729 | 0 | false | Here, we show that siRNA-mediated gene silencing of IKKβ prevented TNF-α–induced insulin resistance on glucose uptake and metabolism in cultured myotubes, with a concomitant increase in phosphorylation of Akt, and AS160. | [
"at Ser473, Thr308"
] | Here, we show that siRNA-mediated gene silencing of IKKβ prevented TNF-α–induced insulin resistance on glucose uptake and metabolism in cultured myotubes, with a concomitant increase in phosphorylation of Akt, and AS160. | true | true | true | true | true | 7,405 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | Inhibition of ERK signaling using pharmacological inhibitor PD98059 did not alter TNF-α–mediated reduction in insulin-stimulated glycogen synthesis. | [
"47",
"25",
"26",
"48"
] | 148 | 42,730 | 0 | false | Inhibition of ERK signaling using pharmacological inhibitor PD98059 did not alter TNF-α–mediated reduction in insulin-stimulated glycogen synthesis. | [] | Inhibition of ERK signaling using pharmacological inhibitor PD98059 did not alter TNF-α–mediated reduction in insulin-stimulated glycogen synthesis. | true | true | true | true | true | 7,405 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | Furthermore, the TNF-α–mediated activation of ERK and JNK was unaffected by the siRNA-mediated reduction of IKKβ. | [
"47",
"25",
"26",
"48"
] | 113 | 42,731 | 0 | false | Furthermore, the TNF-α–mediated activation of ERK and JNK was unaffected by the siRNA-mediated reduction of IKKβ. | [] | Furthermore, the TNF-α–mediated activation of ERK and JNK was unaffected by the siRNA-mediated reduction of IKKβ. | true | true | true | true | true | 7,405 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | Additionally, the siRNA-mediated reduction of IKKβ did not prevent TNF-α–induced IRS-1 serine phosphorylation on Ser312 or the IRS-1 mobility shift as determined by SDS-PAGE. | [
"47",
"25",
"26",
"48"
] | 174 | 42,732 | 0 | false | Additionally, the siRNA-mediated reduction of IKKβ did not prevent TNF-α–induced IRS-1 serine phosphorylation on Ser312 or the IRS-1 mobility shift as determined by SDS-PAGE. | [] | Additionally, the siRNA-mediated reduction of IKKβ did not prevent TNF-α–induced IRS-1 serine phosphorylation on Ser312 or the IRS-1 mobility shift as determined by SDS-PAGE. | true | true | true | true | true | 7,405 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | This is in contrast to some reports indicating that inhibition of IKKβ prevents IRS-1 Ser307 (equivalent to human IRS-1 Ser312) phosphorylation in cultured HEPG2, 3T3-L1 adipocytes, or embryonic kidney cells (25,26,48) but is consistent with other observations that IKKβ is disassociated from IRS-1 phosphorylation (Stev... | [
"47",
"25",
"26",
"48"
] | 396 | 42,733 | 0 | false | This is in contrast to some reports indicating that inhibition of IKKβ prevents IRS-1 Ser307 (equivalent to human IRS-1 Ser312) phosphorylation in cultured HEPG2, 3T3-L1 adipocytes, or embryonic kidney cells but is consistent with other observations that IKKβ is disassociated from IRS-1 phosphorylation (Steven E. Shoel... | [
"25,26,48"
] | This is in contrast to some reports indicating that inhibition of IKKβ prevents IRS-1 Ser307 (equivalent to human IRS-1 Ser312) phosphorylation in cultured HEPG2, 3T3-L1 adipocytes, or embryonic kidney cells but is consistent with other observations that IKKβ is disassociated from IRS-1 phosphorylation (Steven E. Shoel... | true | true | true | true | true | 7,405 |
4 | DISCUSSION | 1 | 47 | [
"r47",
"r25",
"r26",
"r48"
] | 18,443,205 | pmid-17498510|pmid-12714600|pmid-12409308|pmid-14764603 | Our results indicate that the TNF-α effect on IRS-1 serine phosphorylation is primarily mediated via parallel IKKβ independent pathways, such as JNK. | [
"47",
"25",
"26",
"48"
] | 149 | 42,734 | 0 | false | Our results indicate that the TNF-α effect on IRS-1 serine phosphorylation is primarily mediated via parallel IKKβ independent pathways, such as JNK. | [] | Our results indicate that the TNF-α effect on IRS-1 serine phosphorylation is primarily mediated via parallel IKKβ independent pathways, such as JNK. | true | true | true | true | true | 7,405 |
5 | DISCUSSION | 0 | null | null | 18,443,205 | null | IKKβ silencing fully restored the TNF-α–mediated reduction of insulin-stimulated glucose metabolism, despite modest impairments in insulin signaling at the level of Akt. | null | 169 | 42,735 | 0 | false | null | null | IKKβ silencing fully restored the TNF-α–mediated reduction of insulin-stimulated glucose metabolism, despite modest impairments in insulin signaling at the level of Akt. | true | true | true | true | true | 7,406 |
5 | DISCUSSION | 0 | null | null | 18,443,205 | null | However, TNF-α exposure was associated with a profound impairment in insulin-stimulated AS160 phosphorylation, which was restored following IKKβ silencing. | null | 155 | 42,736 | 0 | false | null | null | However, TNF-α exposure was associated with a profound impairment in insulin-stimulated AS160 phosphorylation, which was restored following IKKβ silencing. | true | true | true | true | true | 7,406 |
5 | DISCUSSION | 0 | null | null | 18,443,205 | null | Since AS160 is a critical step in the processes involved from insulin signaling to glucose transport, this may explain the enhanced glucose metabolism in IKKβ-depleted myotubes. | null | 177 | 42,737 | 0 | false | null | null | Since AS160 is a critical step in the processes involved from insulin signaling to glucose transport, this may explain the enhanced glucose metabolism in IKKβ-depleted myotubes. | true | true | true | true | true | 7,406 |
5 | DISCUSSION | 0 | null | null | 18,443,205 | null | Our results may also indicate that a relatively small pool of total Akt is critical for signaling to AS160, and this pool may be highly sensitive to TNF-α, possibly due to cellular localization. | null | 194 | 42,738 | 0 | false | null | null | Our results may also indicate that a relatively small pool of total Akt is critical for signaling to AS160, and this pool may be highly sensitive to TNF-α, possibly due to cellular localization. | true | true | true | true | true | 7,406 |
6 | DISCUSSION | 1 | 49 | [
"r49",
"r50",
"r51"
] | 18,443,205 | pmid-12584189|pmid-16960890|pmid-16007092 | In primary cultures of human muscle, TNF-α exposure enhanced phosphorylation of GSK3β. | [
"49",
"50",
"51"
] | 86 | 42,739 | 0 | false | In primary cultures of human muscle, TNF-α exposure enhanced phosphorylation of GSK3β. | [] | In primary cultures of human muscle, TNF-α exposure enhanced phosphorylation of GSK3β. | true | true | true | true | true | 7,407 |
6 | DISCUSSION | 1 | 49 | [
"r49",
"r50",
"r51"
] | 18,443,205 | pmid-12584189|pmid-16960890|pmid-16007092 | This finding is consistent with a finding of a previous study in HEK293 cells and mouse embryonic fibroblasts (49), where TNF-α–mediated activation of ERK was partly dependent on GSK3β phosphorylation. | [
"49",
"50",
"51"
] | 201 | 42,740 | 1 | false | This finding is consistent with a finding of a previous study in HEK293 cells and mouse embryonic fibroblasts, where TNF-α–mediated activation of ERK was partly dependent on GSK3β phosphorylation. | [
"49"
] | This finding is consistent with a finding of a previous study in HEK293 cells and mouse embryonic fibroblasts, where TNF-α–mediated activation of ERK was partly dependent on GSK3β phosphorylation. | true | true | true | true | true | 7,407 |
6 | DISCUSSION | 1 | 50 | [
"r49",
"r50",
"r51"
] | 18,443,205 | pmid-12584189|pmid-16960890|pmid-16007092 | Conversely, TNF-α exposure has also been shown to prevent insulin-stimulated phosphorylation of GSK3β in HEPG2 cells (50). | [
"49",
"50",
"51"
] | 122 | 42,741 | 1 | false | Conversely, TNF-α exposure has also been shown to prevent insulin-stimulated phosphorylation of GSK3β in HEPG2 cells. | [
"50"
] | Conversely, TNF-α exposure has also been shown to prevent insulin-stimulated phosphorylation of GSK3β in HEPG2 cells. | true | true | true | true | true | 7,407 |
6 | DISCUSSION | 1 | 49 | [
"r49",
"r50",
"r51"
] | 18,443,205 | pmid-12584189|pmid-16960890|pmid-16007092 | Here, we report that IKKβ silencing prevents the TNF-α–mediated increase in GSK3β phosphorylation; however, the functional consequence requires further investigation. | [
"49",
"50",
"51"
] | 166 | 42,742 | 0 | false | Here, we report that IKKβ silencing prevents the TNF-α–mediated increase in GSK3β phosphorylation; however, the functional consequence requires further investigation. | [] | Here, we report that IKKβ silencing prevents the TNF-α–mediated increase in GSK3β phosphorylation; however, the functional consequence requires further investigation. | true | true | true | true | true | 7,407 |
6 | DISCUSSION | 1 | 51 | [
"r49",
"r50",
"r51"
] | 18,443,205 | pmid-12584189|pmid-16960890|pmid-16007092 | Although GSK3β Ser9 phosphorylation has been linked to a reduction in the constitutive ability of GSK3 to phosphorylate Ser641 of glycogen synthase, it does not completely abolish the ability of GSK3 to phosphorylate glycogen synthase (51). | [
"49",
"50",
"51"
] | 240 | 42,743 | 1 | false | Although GSK3β Ser9 phosphorylation has been linked to a reduction in the constitutive ability of GSK3 to phosphorylate Ser641 of glycogen synthase, it does not completely abolish the ability of GSK3 to phosphorylate glycogen synthase. | [
"51"
] | Although GSK3β Ser9 phosphorylation has been linked to a reduction in the constitutive ability of GSK3 to phosphorylate Ser641 of glycogen synthase, it does not completely abolish the ability of GSK3 to phosphorylate glycogen synthase. | true | true | true | true | true | 7,407 |
6 | DISCUSSION | 1 | 49 | [
"r49",
"r50",
"r51"
] | 18,443,205 | pmid-12584189|pmid-16960890|pmid-16007092 | Thus, further studies are warranted to establish whether GSK3 activity is modulated. | [
"49",
"50",
"51"
] | 84 | 42,744 | 0 | false | Thus, further studies are warranted to establish whether GSK3 activity is modulated. | [] | Thus, further studies are warranted to establish whether GSK3 activity is modulated. | true | true | true | true | true | 7,407 |
7 | DISCUSSION | 1 | 23 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | MAP4K4 is a member of the NCK interacting kinase family (23). | [
"23",
"34",
"22"
] | 61 | 42,745 | 1 | false | MAP4K4 is a member of the NCK interacting kinase family. | [
"23"
] | MAP4K4 is a member of the NCK interacting kinase family. | true | true | true | true | true | 7,408 |
7 | DISCUSSION | 1 | 34 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | NCK interacting kinase family kinases are potent activators of the IKK complex and activators of ERK and JNK (34), which suggests that MAP4K4 is likely to be an upstream regulator of IKKβ. | [
"23",
"34",
"22"
] | 188 | 42,746 | 1 | false | NCK interacting kinase family kinases are potent activators of the IKK complex and activators of ERK and JNK, which suggests that MAP4K4 is likely to be an upstream regulator of IKKβ. | [
"34"
] | NCK interacting kinase family kinases are potent activators of the IKK complex and activators of ERK and JNK, which suggests that MAP4K4 is likely to be an upstream regulator of IKKβ. | true | true | true | true | true | 7,408 |
7 | DISCUSSION | 1 | 23 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | Here, we show that siRNA-mediated silencing of IKKβ had no effect on expression of MAP4K4, excluding a negative feedback on this upstream kinase. | [
"23",
"34",
"22"
] | 145 | 42,747 | 0 | false | Here, we show that siRNA-mediated silencing of IKKβ had no effect on expression of MAP4K4, excluding a negative feedback on this upstream kinase. | [] | Here, we show that siRNA-mediated silencing of IKKβ had no effect on expression of MAP4K4, excluding a negative feedback on this upstream kinase. | true | true | true | true | true | 7,408 |
7 | DISCUSSION | 1 | 22 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | We have previously reported that the siRNA-mediated reduction of MAP4K4 rescues TNF-α–mediated insulin resistance in primary human skeletal muscle cultures (22), consistent with our present findings for IKKβ. | [
"23",
"34",
"22"
] | 208 | 42,748 | 1 | false | We have previously reported that the siRNA-mediated reduction of MAP4K4 rescues TNF-α–mediated insulin resistance in primary human skeletal muscle cultures, consistent with our present findings for IKKβ. | [
"22"
] | We have previously reported that the siRNA-mediated reduction of MAP4K4 rescues TNF-α–mediated insulin resistance in primary human skeletal muscle cultures, consistent with our present findings for IKKβ. | true | true | true | true | true | 7,408 |
7 | DISCUSSION | 1 | 23 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | Although a reduction of either MAP4K4 or IKKβ prevents the effect of TNF-α on insulin-mediated glucose uptake and metabolism, the reduction of MAP4K4 also prevented IRS-1 serine phosphorylation and signaling to ERK 1/2 and JNK. | [
"23",
"34",
"22"
] | 227 | 42,749 | 0 | false | Although a reduction of either MAP4K4 or IKKβ prevents the effect of TNF-α on insulin-mediated glucose uptake and metabolism, the reduction of MAP4K4 also prevented IRS-1 serine phosphorylation and signaling to ERK 1/2 and JNK. | [] | Although a reduction of either MAP4K4 or IKKβ prevents the effect of TNF-α on insulin-mediated glucose uptake and metabolism, the reduction of MAP4K4 also prevented IRS-1 serine phosphorylation and signaling to ERK 1/2 and JNK. | true | true | true | true | true | 7,408 |
7 | DISCUSSION | 1 | 23 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | In contrast, siRNA silencing of IKKβ did not alter TNF-α signaling to either IRS-1 Ser312, JNK, or ERK phosphorylation. | [
"23",
"34",
"22"
] | 119 | 42,750 | 0 | false | In contrast, siRNA silencing of IKKβ did not alter TNF-α signaling to either IRS-1 Ser312, JNK, or ERK phosphorylation. | [] | In contrast, siRNA silencing of IKKβ did not alter TNF-α signaling to either IRS-1 Ser312, JNK, or ERK phosphorylation. | true | true | true | true | true | 7,408 |
7 | DISCUSSION | 1 | 23 | [
"r23",
"r34",
"r22"
] | 18,443,205 | pmid-16461467|pmid-15951441|pmid-17227768 | These results are consistent with the hypothesis that downstream signals from MAP4K4 diverge toward an ERK/JNK pathway that mediates effects on IRS-1 serine phosphorylation and an IKKβ pathway that mediates effects on glucose uptake and metabolism. | [
"23",
"34",
"22"
] | 248 | 42,751 | 0 | false | These results are consistent with the hypothesis that downstream signals from MAP4K4 diverge toward an ERK/JNK pathway that mediates effects on IRS-1 serine phosphorylation and an IKKβ pathway that mediates effects on glucose uptake and metabolism. | [] | These results are consistent with the hypothesis that downstream signals from MAP4K4 diverge toward an ERK/JNK pathway that mediates effects on IRS-1 serine phosphorylation and an IKKβ pathway that mediates effects on glucose uptake and metabolism. | true | true | true | true | true | 7,408 |
8 | DISCUSSION | 0 | null | null | 18,443,205 | null | In summary, targeted deletion of IKKβ using siRNA prevents TNF-α–mediated insulin resistance on Akt and AS160 phosphorylation and glucose uptake and metabolism in human skeletal muscle. | null | 185 | 42,752 | 0 | false | null | null | In summary, targeted deletion of IKKβ using siRNA prevents TNF-α–mediated insulin resistance on Akt and AS160 phosphorylation and glucose uptake and metabolism in human skeletal muscle. | true | true | true | true | true | 7,409 |
8 | DISCUSSION | 0 | null | null | 18,443,205 | null | These results underscore IKKβ as a potential therapeutic target to prevent peripheral insulin resistance. | null | 105 | 42,753 | 0 | false | null | null | These results underscore IKKβ as a potential therapeutic target to prevent peripheral insulin resistance. | true | true | true | true | true | 7,409 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | During the past few years, Yang et al. | [
"12",
"13",
"15"
] | 38 | 42,754 | 0 | false | During the past few years, Yang et al. | [] | During the past few years, Yang et al. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | (12, 13) showed that an FTI ameliorates disease phenotypes in a mouse model of HGPS. | [
"12",
"13",
"15"
] | 84 | 42,755 | 0 | false | showed that an FTI ameliorates disease phenotypes in a mouse model of HGPS. | [
"12, 13"
] | showed that an FTI ameliorates disease phenotypes in a mouse model of HGPS. | false | true | true | true | false | 7,410 |
0 | DISCUSSION | 1 | 15 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | Although the results were significant and reproducible, putting the findings into perspective is challenging, particularly with the discovery that LmnanHG/+ mice develop disease (15). | [
"12",
"13",
"15"
] | 183 | 42,756 | 1 | false | Although the results were significant and reproducible, putting the findings into perspective is challenging, particularly with the discovery that LmnanHG/+ mice develop disease. | [
"15"
] | Although the results were significant and reproducible, putting the findings into perspective is challenging, particularly with the discovery that LmnanHG/+ mice develop disease. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | LmnanHG/+ have all of the same progeria-like disease phenotypes as LmnaHG/+ mice, albeit somewhat milder, and they invariably succumb to the disease. | [
"12",
"13",
"15"
] | 149 | 42,757 | 0 | false | LmnanHG/+ have all of the same progeria-like disease phenotypes as LmnaHG/+ mice, albeit somewhat milder, and they invariably succumb to the disease. | [] | LmnanHG/+ have all of the same progeria-like disease phenotypes as LmnaHG/+ mice, albeit somewhat milder, and they invariably succumb to the disease. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | The discovery that nonfarnesylated progerin elicits disease prompted us to consider the possibility that the beneficial effects of the FTI in LmnaHG/+ mice might have little to do with a direct effect on the farnesylation of progerin. | [
"12",
"13",
"15"
] | 234 | 42,758 | 0 | false | The discovery that nonfarnesylated progerin elicits disease prompted us to consider the possibility that the beneficial effects of the FTI in LmnaHG/+ mice might have little to do with a direct effect on the farnesylation of progerin. | [] | The discovery that nonfarnesylated progerin elicits disease prompted us to consider the possibility that the beneficial effects of the FTI in LmnaHG/+ mice might have little to do with a direct effect on the farnesylation of progerin. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | Instead, we wondered whether the effect of the FTI might be more indirect, perhaps secondary to inhibiting the farnesylation of other cellular proteins. | [
"12",
"13",
"15"
] | 152 | 42,759 | 0 | false | Instead, we wondered whether the effect of the FTI might be more indirect, perhaps secondary to inhibiting the farnesylation of other cellular proteins. | [] | Instead, we wondered whether the effect of the FTI might be more indirect, perhaps secondary to inhibiting the farnesylation of other cellular proteins. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | If the effects of the FTI were indirect, one would predict the FTI might be equally efficacious in LmnaHG/+ and LmnanHG/+ mice. | [
"12",
"13",
"15"
] | 127 | 42,760 | 0 | false | If the effects of the FTI were indirect, one would predict the FTI might be equally efficacious in LmnaHG/+ and LmnanHG/+ mice. | [] | If the effects of the FTI were indirect, one would predict the FTI might be equally efficacious in LmnaHG/+ and LmnanHG/+ mice. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | This prediction was not borne out. | [
"12",
"13",
"15"
] | 34 | 42,761 | 0 | false | This prediction was not borne out. | [] | This prediction was not borne out. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | FTI treatment had no effect on body weight, survival, the number of rib fractures, fat stores, bone cortical thickness, or bone density of LmnanHG/+ mice. | [
"12",
"13",
"15"
] | 154 | 42,762 | 0 | false | FTI treatment had no effect on body weight, survival, the number of rib fractures, fat stores, bone cortical thickness, or bone density of LmnanHG/+ mice. | [] | FTI treatment had no effect on body weight, survival, the number of rib fractures, fat stores, bone cortical thickness, or bone density of LmnanHG/+ mice. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | In contrast, the FTI improved all of these phenotypes in LmnaHG/+ mice, and did so in a highly significant fashion. | [
"12",
"13",
"15"
] | 115 | 42,763 | 0 | false | In contrast, the FTI improved all of these phenotypes in LmnaHG/+ mice, and did so in a highly significant fashion. | [] | In contrast, the FTI improved all of these phenotypes in LmnaHG/+ mice, and did so in a highly significant fashion. | true | true | true | true | true | 7,410 |
0 | DISCUSSION | 1 | 12 | [
"bib12",
"bib13",
"bib15"
] | 19,965,595 | pmid-16862216|pmid-16484451|pmid-18769635 | The fact that the FTI improved disease in LmnaHG/+ but not LmnanHG/+ mice suggests that the beneficial effect of the FTI in LmnaHG/+ mice is likely a consequence of inhibiting the prenylation of progerin, rather than an indirect effect of the drug on other cellular proteins. | [
"12",
"13",
"15"
] | 275 | 42,764 | 0 | false | The fact that the FTI improved disease in LmnaHG/+ but not LmnanHG/+ mice suggests that the beneficial effect of the FTI in LmnaHG/+ mice is likely a consequence of inhibiting the prenylation of progerin, rather than an indirect effect of the drug on other cellular proteins. | [] | The fact that the FTI improved disease in LmnaHG/+ but not LmnanHG/+ mice suggests that the beneficial effect of the FTI in LmnaHG/+ mice is likely a consequence of inhibiting the prenylation of progerin, rather than an indirect effect of the drug on other cellular proteins. | true | true | true | true | true | 7,410 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | The beneficial effects of the FTI on disease phenotypes in LmnaHG/+ mice were very apparent, and most of the differences were significant at a P < 0.0001 level. | [
"20",
"8",
"14",
"15"
] | 160 | 42,765 | 0 | false | The beneficial effects of the FTI on disease phenotypes in LmnaHG/+ mice were very apparent, and most of the differences were significant at a P < 0.0001 level. | [] | The beneficial effects of the FTI on disease phenotypes in LmnaHG/+ mice were very apparent, and most of the differences were significant at a P < 0.0001 level. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | In contrast, the FTI had no significant effects in LmnanHG/+ mice. | [
"20",
"8",
"14",
"15"
] | 66 | 42,766 | 0 | false | In contrast, the FTI had no significant effects in LmnanHG/+ mice. | [] | In contrast, the FTI had no significant effects in LmnanHG/+ mice. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | One could argue that there may have been a slight trend toward improved body weights and lower numbers of rib fractures in FTI-treated LmnanHG/+ mice, but these differences did not achieve statistical significance. | [
"20",
"8",
"14",
"15"
] | 214 | 42,767 | 0 | false | One could argue that there may have been a slight trend toward improved body weights and lower numbers of rib fractures in FTI-treated LmnanHG/+ mice, but these differences did not achieve statistical significance. | [] | One could argue that there may have been a slight trend toward improved body weights and lower numbers of rib fractures in FTI-treated LmnanHG/+ mice, but these differences did not achieve statistical significance. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | We suspect that the trend simply reflected the play of chance. | [
"20",
"8",
"14",
"15"
] | 62 | 42,768 | 0 | false | We suspect that the trend simply reflected the play of chance. | [] | We suspect that the trend simply reflected the play of chance. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | However, if one were forced to suggest a potential explanation for the trend, one could point to the lower levels of mature lamin A in the setting of FTI treatment. | [
"20",
"8",
"14",
"15"
] | 164 | 42,769 | 0 | false | However, if one were forced to suggest a potential explanation for the trend, one could point to the lower levels of mature lamin A in the setting of FTI treatment. | [] | However, if one were forced to suggest a potential explanation for the trend, one could point to the lower levels of mature lamin A in the setting of FTI treatment. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | Genetic studies have suggested that lower levels of lamin A synthesis reduce the disease phenotypes elicited by a LmnaHG allele (20). | [
"20",
"8",
"14",
"15"
] | 133 | 42,770 | 1 | false | Genetic studies have suggested that lower levels of lamin A synthesis reduce the disease phenotypes elicited by a LmnaHG allele. | [
"20"
] | Genetic studies have suggested that lower levels of lamin A synthesis reduce the disease phenotypes elicited by a LmnaHG allele. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | The finding of lower lamin A levels in association with FTI treatment was also observed in earlier studies (8, 14, 15). | [
"20",
"8",
"14",
"15"
] | 119 | 42,771 | 0 | false | The finding of lower lamin A levels in association with FTI treatment was also observed in earlier studies. | [
"8, 14, 15"
] | The finding of lower lamin A levels in association with FTI treatment was also observed in earlier studies. | true | true | true | true | true | 7,411 |
1 | DISCUSSION | 1 | 20 | [
"bib20",
"bib8",
"bib14",
"bib15"
] | 19,965,595 | pmid-18178963|pmid-16129834|pmid-18082640|pmid-18769635 | The mechanism for the fall in lamin A levels is unclear but we suspect that sustained blockade of prelamin A farnesylation leads to the eventual turnover of nonfarnesylated prelamin A, reducing the production of mature lamin A. | [
"20",
"8",
"14",
"15"
] | 227 | 42,772 | 0 | false | The mechanism for the fall in lamin A levels is unclear but we suspect that sustained blockade of prelamin A farnesylation leads to the eventual turnover of nonfarnesylated prelamin A, reducing the production of mature lamin A. | [] | The mechanism for the fall in lamin A levels is unclear but we suspect that sustained blockade of prelamin A farnesylation leads to the eventual turnover of nonfarnesylated prelamin A, reducing the production of mature lamin A. | true | true | true | true | true | 7,411 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | The current study reinforces the idea that an FTI can ameliorate disease in LmnaHG/+ mice, but important questions remain about the utility of FTIs in the treatment of humans with HGPS. | [
"21",
"21"
] | 185 | 42,773 | 0 | false | The current study reinforces the idea that an FTI can ameliorate disease in LmnaHG/+ mice, but important questions remain about the utility of FTIs in the treatment of humans with HGPS. | [] | The current study reinforces the idea that an FTI can ameliorate disease in LmnaHG/+ mice, but important questions remain about the utility of FTIs in the treatment of humans with HGPS. | true | true | true | true | true | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | Indeed, questions were raised about whether an FTI is the most appropriate drug for inhibiting the prenylation of progerin (21). | [
"21",
"21"
] | 128 | 42,774 | 1 | false | Indeed, questions were raised about whether an FTI is the most appropriate drug for inhibiting the prenylation of progerin. | [
"21"
] | Indeed, questions were raised about whether an FTI is the most appropriate drug for inhibiting the prenylation of progerin. | true | true | true | true | true | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | Varela et al. | [
"21",
"21"
] | 13 | 42,775 | 0 | false | Varela et al. | [] | Varela et al. | true | true | true | true | true | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | (21) reported data suggesting that progerin can be geranylgeranylated in the setting of an FTI, and they proposed that a combination of a statin and a bisphosphonate (which would theoretically inhibit both farnesylation and geranylgeranylation) might be more useful for treating HGPS. | [
"21",
"21"
] | 284 | 42,776 | 1 | false | reported data suggesting that progerin can be geranylgeranylated in the setting of an FTI, and they proposed that a combination of a statin and a bisphosphonate (which would theoretically inhibit both farnesylation and geranylgeranylation) might be more useful for treating HGPS. | [
"21"
] | reported data suggesting that progerin can be geranylgeranylated in the setting of an FTI, and they proposed that a combination of a statin and a bisphosphonate (which would theoretically inhibit both farnesylation and geranylgeranylation) might be more useful for treating HGPS. | false | true | true | true | false | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | They went on to show that a statin/bisphosphonate combination improved progeria-like disease phenotypes in ZMPSTE24-deficient mice; however, they provided no evidence that the combination actually inhibited the prenylation of prelamin A (or any other protein) in mice. | [
"21",
"21"
] | 268 | 42,777 | 0 | false | They went on to show that a statin/bisphosphonate combination improved progeria-like disease phenotypes in ZMPSTE24-deficient mice; however, they provided no evidence that the combination actually inhibited the prenylation of prelamin A (or any other protein) in mice. | [] | They went on to show that a statin/bisphosphonate combination improved progeria-like disease phenotypes in ZMPSTE24-deficient mice; however, they provided no evidence that the combination actually inhibited the prenylation of prelamin A (or any other protein) in mice. | true | true | true | true | true | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | Until such evidence is in hand, doubts will remain about the rationale for the statin/bisphosphonate combination, and in particular, whether the combination ameliorates disease indirectly (perhaps secondary to the bone-strengthening properties of bisphosphonates) or more directly by inhibiting the prenylation of prelam... | [
"21",
"21"
] | 325 | 42,778 | 0 | false | Until such evidence is in hand, doubts will remain about the rationale for the statin/bisphosphonate combination, and in particular, whether the combination ameliorates disease indirectly (perhaps secondary to the bone-strengthening properties of bisphosphonates) or more directly by inhibiting the prenylation of prelam... | [] | Until such evidence is in hand, doubts will remain about the rationale for the statin/bisphosphonate combination, and in particular, whether the combination ameliorates disease indirectly (perhaps secondary to the bone-strengthening properties of bisphosphonates) or more directly by inhibiting the prenylation of prelam... | true | true | true | true | true | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | For those interested in investigating the utility of a bisphosphonate/statin combination, the approach outlined in the current study should be of interest. | [
"21",
"21"
] | 155 | 42,779 | 0 | false | For those interested in investigating the utility of a bisphosphonate/statin combination, the approach outlined in the current study should be of interest. | [] | For those interested in investigating the utility of a bisphosphonate/statin combination, the approach outlined in the current study should be of interest. | true | true | true | true | true | 7,412 |
2 | DISCUSSION | 1 | 21 | [
"bib21",
"bib21"
] | 19,965,595 | pmid-18587406|pmid-18587406 | If a statin/bisphosphonate combination were to improve disease phenotypes in LmnanHG/+ mice, that would suggest that the mechanism for the combination was likely indirect, perhaps due to the bone-strengthening properties of the bisphosphonates, and not to a specific effect on the prenylation of prelamin A. | [
"21",
"21"
] | 307 | 42,780 | 0 | false | If a statin/bisphosphonate combination were to improve disease phenotypes in LmnanHG/+ mice, that would suggest that the mechanism for the combination was likely indirect, perhaps due to the bone-strengthening properties of the bisphosphonates, and not to a specific effect on the prenylation of prelamin A. | [] | If a statin/bisphosphonate combination were to improve disease phenotypes in LmnanHG/+ mice, that would suggest that the mechanism for the combination was likely indirect, perhaps due to the bone-strengthening properties of the bisphosphonates, and not to a specific effect on the prenylation of prelamin A. | true | true | true | true | true | 7,412 |
3 | DISCUSSION | 0 | null | null | 19,965,595 | null | In summary, an FTI ameliorates disease phenotypes in LmnaHG/+ mice, but not LmnanHG/+ mice. | null | 91 | 42,781 | 0 | false | null | null | In summary, an FTI ameliorates disease phenotypes in LmnaHG/+ mice, but not LmnanHG/+ mice. | true | true | true | true | true | 7,413 |
3 | DISCUSSION | 0 | null | null | 19,965,595 | null | The failure of the FTI to improve disease in LmnanHG/+ mice suggests that the beneficial effects of the drug in LmnaHG/+ mice are likely due to blocking the farnesylation of progerin. | null | 183 | 42,782 | 0 | false | null | null | The failure of the FTI to improve disease in LmnanHG/+ mice suggests that the beneficial effects of the drug in LmnaHG/+ mice are likely due to blocking the farnesylation of progerin. | true | true | true | true | true | 7,413 |
0 | INTRODUCTION | 0 | null | null | 20,466,808 | null | Small non-coding RNAs, in particular microRNAs (miRNAs), have been identified to regulate global gene expression patterns. | null | 122 | 42,783 | 0 | false | null | null | Small non-coding RNAs, in particular microRNAs (miRNAs), have been identified to regulate global gene expression patterns. | true | true | true | true | true | 7,414 |
0 | INTRODUCTION | 0 | null | null | 20,466,808 | null | MiRNAs are transcribed as long precursors and then cleaved to pre-miRNAs of characteristic hairpin structure. | null | 109 | 42,784 | 0 | false | null | null | MiRNAs are transcribed as long precursors and then cleaved to pre-miRNAs of characteristic hairpin structure. | true | true | true | true | true | 7,414 |
0 | INTRODUCTION | 0 | null | null | 20,466,808 | null | Pre-miRNAs are further processed to generate mature miRNAs. | null | 59 | 42,785 | 0 | false | null | null | Pre-miRNAs are further processed to generate mature miRNAs. | true | true | true | true | true | 7,414 |
0 | INTRODUCTION | 0 | null | null | 20,466,808 | null | For several pre-miRNAs, both strands are processed and give rise to a functional miRNA. | null | 87 | 42,786 | 0 | false | null | null | For several pre-miRNAs, both strands are processed and give rise to a functional miRNA. | true | true | true | true | true | 7,414 |
0 | INTRODUCTION | 0 | null | null | 20,466,808 | null | If either one is known to be expressed at <15% of the other form, it is designated as miRNA* (star form). | null | 105 | 42,787 | 0 | false | null | null | If either one is known to be expressed at <15% of the other form, it is designated as miRNA* (star form). | true | true | true | true | true | 7,414 |
0 | INTRODUCTION | 0 | null | null | 20,466,808 | null | If the expression ratio is not known, a mature miRNA is designated with suffix ‘-3p’ or ‘-5p’, depending on the originating strand. | null | 131 | 42,788 | 0 | false | null | null | If the expression ratio is not known, a mature miRNA is designated with suffix ‘-3p’ or ‘-5p’, depending on the originating strand. | true | true | true | true | true | 7,414 |
1 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4"
] | 20,466,808 | pmid-19255566|pmid-14744438|pmid-16557279|pmid-19630570 | Functional miRNAs regulate the translation and cleavage of mRNAs by sequence-specific interaction with the 3′-UTR [reviewed in (1)]. | [
"1",
"2",
"3",
"4"
] | 132 | 42,789 | 0 | false | Functional miRNAs regulate the translation and cleavage of mRNAs by sequence-specific interaction with the 3′-UTR. | [
"reviewed in (1)"
] | Functional miRNAs regulate the translation and cleavage of mRNAs by sequence-specific interaction with the 3′-UTR. | true | true | true | true | true | 7,415 |
1 | INTRODUCTION | 1 | 2 | [
"B1",
"B2",
"B3",
"B4"
] | 20,466,808 | pmid-19255566|pmid-14744438|pmid-16557279|pmid-19630570 | MiRNAs are involved in the regulation of most physiological processes, including differentiation, development and apoptosis (2). | [
"1",
"2",
"3",
"4"
] | 128 | 42,790 | 1 | false | MiRNAs are involved in the regulation of most physiological processes, including differentiation, development and apoptosis. | [
"2"
] | MiRNAs are involved in the regulation of most physiological processes, including differentiation, development and apoptosis. | true | true | true | true | true | 7,415 |
1 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4"
] | 20,466,808 | pmid-19255566|pmid-14744438|pmid-16557279|pmid-19630570 | In cancer, miRNAs may exert oncogenic function by inhibiting tumor suppressor genes or may act as tumor suppressors by inhibiting oncogenes (3,4). | [
"1",
"2",
"3",
"4"
] | 146 | 42,791 | 0 | false | In cancer, miRNAs may exert oncogenic function by inhibiting tumor suppressor genes or may act as tumor suppressors by inhibiting oncogenes. | [
"3,4"
] | In cancer, miRNAs may exert oncogenic function by inhibiting tumor suppressor genes or may act as tumor suppressors by inhibiting oncogenes. | true | true | true | true | true | 7,415 |
2 | INTRODUCTION | 1 | 5–7 | [
"B5 B6 B7",
"B8 B9 B10 B11 B12 B13 B14 B15 B16 B17 B18 B19 B20 B21",
"B22",
"B23"
] | 20,466,808 | pmid-12612655|pmid-17586306|pmid-12901961|pmid-18230126|pmid-17283129|pmid-18505919|pmid-19713529|pmid-18493594|pmid-17604727|pmid-18940866|pmid-19531210|pmid-17943719|pmid-19706822|pmid-18504438|pmid-17297439|pmid-19924232|pmid-19946337|pmid-18639376|pmid-19199973 | Neuroblastoma (NB) is the most common extracranial, solid tumor of childhood, comprising 15% of childhood cancer deaths [reviewed in (5–7)]. | [
"5–7",
"8–21",
"22",
"23"
] | 140 | 42,792 | 0 | false | Neuroblastoma (NB) is the most common extracranial, solid tumor of childhood, comprising 15% of childhood cancer deaths. | [
"reviewed in (5–7)"
] | Neuroblastoma (NB) is the most common extracranial, solid tumor of childhood, comprising 15% of childhood cancer deaths. | true | true | true | true | true | 7,416 |
2 | INTRODUCTION | 1 | 5–7 | [
"B5 B6 B7",
"B8 B9 B10 B11 B12 B13 B14 B15 B16 B17 B18 B19 B20 B21",
"B22",
"B23"
] | 20,466,808 | pmid-12612655|pmid-17586306|pmid-12901961|pmid-18230126|pmid-17283129|pmid-18505919|pmid-19713529|pmid-18493594|pmid-17604727|pmid-18940866|pmid-19531210|pmid-17943719|pmid-19706822|pmid-18504438|pmid-17297439|pmid-19924232|pmid-19946337|pmid-18639376|pmid-19199973 | NB is characterized by a broad clinical and biological heterogeneity. | [
"5–7",
"8–21",
"22",
"23"
] | 69 | 42,793 | 0 | false | NB is characterized by a broad clinical and biological heterogeneity. | [] | NB is characterized by a broad clinical and biological heterogeneity. | true | true | true | true | true | 7,416 |
2 | INTRODUCTION | 1 | 5–7 | [
"B5 B6 B7",
"B8 B9 B10 B11 B12 B13 B14 B15 B16 B17 B18 B19 B20 B21",
"B22",
"B23"
] | 20,466,808 | pmid-12612655|pmid-17586306|pmid-12901961|pmid-18230126|pmid-17283129|pmid-18505919|pmid-19713529|pmid-18493594|pmid-17604727|pmid-18940866|pmid-19531210|pmid-17943719|pmid-19706822|pmid-18504438|pmid-17297439|pmid-19924232|pmid-19946337|pmid-18639376|pmid-19199973 | Patients with favorable NB have a very good prognosis as tumor regression or differentiation is often observed even in the absence of specific treatment. | [
"5–7",
"8–21",
"22",
"23"
] | 153 | 42,794 | 0 | false | Patients with favorable NB have a very good prognosis as tumor regression or differentiation is often observed even in the absence of specific treatment. | [] | Patients with favorable NB have a very good prognosis as tumor regression or differentiation is often observed even in the absence of specific treatment. | true | true | true | true | true | 7,416 |
2 | INTRODUCTION | 1 | 5–7 | [
"B5 B6 B7",
"B8 B9 B10 B11 B12 B13 B14 B15 B16 B17 B18 B19 B20 B21",
"B22",
"B23"
] | 20,466,808 | pmid-12612655|pmid-17586306|pmid-12901961|pmid-18230126|pmid-17283129|pmid-18505919|pmid-19713529|pmid-18493594|pmid-17604727|pmid-18940866|pmid-19531210|pmid-17943719|pmid-19706822|pmid-18504438|pmid-17297439|pmid-19924232|pmid-19946337|pmid-18639376|pmid-19199973 | In contrast, most patients with highly aggressive NB, often characterized by amplification of the MYCN oncogene, die despite intensive therapy. | [
"5–7",
"8–21",
"22",
"23"
] | 143 | 42,795 | 0 | false | In contrast, most patients with highly aggressive NB, often characterized by amplification of the MYCN oncogene, die despite intensive therapy. | [] | In contrast, most patients with highly aggressive NB, often characterized by amplification of the MYCN oncogene, die despite intensive therapy. | true | true | true | true | true | 7,416 |
2 | INTRODUCTION | 1 | 8–21 | [
"B5 B6 B7",
"B8 B9 B10 B11 B12 B13 B14 B15 B16 B17 B18 B19 B20 B21",
"B22",
"B23"
] | 20,466,808 | pmid-12612655|pmid-17586306|pmid-12901961|pmid-18230126|pmid-17283129|pmid-18505919|pmid-19713529|pmid-18493594|pmid-17604727|pmid-18940866|pmid-19531210|pmid-17943719|pmid-19706822|pmid-18504438|pmid-17297439|pmid-19924232|pmid-19946337|pmid-18639376|pmid-19199973 | Most recently, attempts were made to analyze the contribution of miRNAs to NB tumor biology (8–21), reviewed in (22,23). | [
"5–7",
"8–21",
"22",
"23"
] | 120 | 42,796 | 1 | false | Most recently, attempts were made to analyze the contribution of miRNAs to NB tumor biology, reviewed in. | [
"8–21",
"22,23"
] | Most recently, attempts were made to analyze the contribution of miRNAs to NB tumor biology, reviewed in. | true | true | true | true | true | 7,416 |
3 | INTRODUCTION | 1 | 9 | [
"B9",
"B15",
"B16",
"B19",
"B12",
"B17",
"B10",
"B18",
"B19",
"B8"
] | 20,466,808 | pmid-17283129|pmid-19531210|pmid-17943719|pmid-17297439|pmid-18493594|pmid-19706822|pmid-18505919|pmid-18504438|pmid-17297439|pmid-18230126 | Several groups analyzed miRNA expression in primary NBs using miRNA microarrays or high-throughput RT-qPCR. | [
"9",
"15",
"16",
"19",
"12",
"17",
"10",
"18",
"19",
"8"
] | 107 | 42,797 | 0 | false | Several groups analyzed miRNA expression in primary NBs using miRNA microarrays or high-throughput RT-qPCR. | [] | Several groups analyzed miRNA expression in primary NBs using miRNA microarrays or high-throughput RT-qPCR. | true | true | true | true | true | 7,417 |
3 | INTRODUCTION | 1 | 9 | [
"B9",
"B15",
"B16",
"B19",
"B12",
"B17",
"B10",
"B18",
"B19",
"B8"
] | 20,466,808 | pmid-17283129|pmid-19531210|pmid-17943719|pmid-17297439|pmid-18493594|pmid-19706822|pmid-18505919|pmid-18504438|pmid-17297439|pmid-18230126 | They reported broad deregulation of miRNA patterns correlated with MYCN amplification, 11q deletion and prognosis (9,15,16,19). | [
"9",
"15",
"16",
"19",
"12",
"17",
"10",
"18",
"19",
"8"
] | 127 | 42,798 | 0 | false | They reported broad deregulation of miRNA patterns correlated with MYCN amplification, 11q deletion and prognosis. | [
"9,15,16,19"
] | They reported broad deregulation of miRNA patterns correlated with MYCN amplification, 11q deletion and prognosis. | true | true | true | true | true | 7,417 |
3 | INTRODUCTION | 1 | 9 | [
"B9",
"B15",
"B16",
"B19",
"B12",
"B17",
"B10",
"B18",
"B19",
"B8"
] | 20,466,808 | pmid-17283129|pmid-19531210|pmid-17943719|pmid-17297439|pmid-18493594|pmid-19706822|pmid-18505919|pmid-18504438|pmid-17297439|pmid-18230126 | Further functional analysis identified miRNAs of the MYCN-regulated miR-17-92 cluster to be important for proliferation and migration as well as invasive growth of NB cells (12, 17). | [
"9",
"15",
"16",
"19",
"12",
"17",
"10",
"18",
"19",
"8"
] | 182 | 42,799 | 0 | false | Further functional analysis identified miRNAs of the MYCN-regulated miR-17-92 cluster to be important for proliferation and migration as well as invasive growth of NB cells. | [
"12, 17"
] | Further functional analysis identified miRNAs of the MYCN-regulated miR-17-92 cluster to be important for proliferation and migration as well as invasive growth of NB cells. | true | true | true | true | true | 7,417 |
3 | INTRODUCTION | 1 | 9 | [
"B9",
"B15",
"B16",
"B19",
"B12",
"B17",
"B10",
"B18",
"B19",
"B8"
] | 20,466,808 | pmid-17283129|pmid-19531210|pmid-17943719|pmid-17297439|pmid-18493594|pmid-19706822|pmid-18505919|pmid-18504438|pmid-17297439|pmid-18230126 | Furthermore, miR-34a, located in a region of frequent chromosomal loss, appears to directly downregulate expression of the MYCN oncogene (10,18,19). | [
"9",
"15",
"16",
"19",
"12",
"17",
"10",
"18",
"19",
"8"
] | 148 | 42,800 | 0 | false | Furthermore, miR-34a, located in a region of frequent chromosomal loss, appears to directly downregulate expression of the MYCN oncogene. | [
"10,18,19"
] | Furthermore, miR-34a, located in a region of frequent chromosomal loss, appears to directly downregulate expression of the MYCN oncogene. | true | true | true | true | true | 7,417 |
3 | INTRODUCTION | 1 | 8 | [
"B9",
"B15",
"B16",
"B19",
"B12",
"B17",
"B10",
"B18",
"B19",
"B8"
] | 20,466,808 | pmid-17283129|pmid-19531210|pmid-17943719|pmid-17297439|pmid-18493594|pmid-19706822|pmid-18505919|pmid-18504438|pmid-17297439|pmid-18230126 | The only attempt to clone NB-specific miRNAs from primary tumors was compromised by the low coverage of the generated libraries (8). | [
"9",
"15",
"16",
"19",
"12",
"17",
"10",
"18",
"19",
"8"
] | 132 | 42,801 | 1 | false | The only attempt to clone NB-specific miRNAs from primary tumors was compromised by the low coverage of the generated libraries. | [
"8"
] | The only attempt to clone NB-specific miRNAs from primary tumors was compromised by the low coverage of the generated libraries. | true | true | true | true | true | 7,417 |
4 | INTRODUCTION | 1 | 24–28 | [
"B24 B25 B26 B27 B28",
"B13",
"B26",
"B29",
"B26",
"B30"
] | 20,466,808 | pmid-18849523|pmid-19564845|pmid-18285502|pmid-19508715|pmid-19390579|pmid-17604727|pmid-18285502|pmid-17599088|pmid-18285502|pmid-15035981 | With the availability of high-throughput next-generation sequencing (NGS) (24–28), the technical drawbacks of probe-based methodologies, especially restriction to detection of only previously known sequences, can be overcome. | [
"24–28",
"13",
"26",
"29",
"26",
"30"
] | 225 | 42,802 | 1 | false | With the availability of high-throughput next-generation sequencing (NGS), the technical drawbacks of probe-based methodologies, especially restriction to detection of only previously known sequences, can be overcome. | [
"24–28"
] | With the availability of high-throughput next-generation sequencing (NGS), the technical drawbacks of probe-based methodologies, especially restriction to detection of only previously known sequences, can be overcome. | true | true | true | true | true | 7,418 |
4 | INTRODUCTION | 1 | 24–28 | [
"B24 B25 B26 B27 B28",
"B13",
"B26",
"B29",
"B26",
"B30"
] | 20,466,808 | pmid-18849523|pmid-19564845|pmid-18285502|pmid-19508715|pmid-19390579|pmid-17604727|pmid-18285502|pmid-17599088|pmid-18285502|pmid-15035981 | As miRNAs are sequenced directly, information about SNPs as well as post-transcriptional RNA editing, 3′-terminal addition of single nucleotides and variation in miRNA length becomes available for further analysis (13,26,29). | [
"24–28",
"13",
"26",
"29",
"26",
"30"
] | 225 | 42,803 | 0 | false | As miRNAs are sequenced directly, information about SNPs as well as post-transcriptional RNA editing, 3′-terminal addition of single nucleotides and variation in miRNA length becomes available for further analysis. | [
"13,26,29"
] | As miRNAs are sequenced directly, information about SNPs as well as post-transcriptional RNA editing, 3′-terminal addition of single nucleotides and variation in miRNA length becomes available for further analysis. | true | true | true | true | true | 7,418 |
4 | INTRODUCTION | 1 | 26 | [
"B24 B25 B26 B27 B28",
"B13",
"B26",
"B29",
"B26",
"B30"
] | 20,466,808 | pmid-18849523|pmid-19564845|pmid-18285502|pmid-19508715|pmid-19390579|pmid-17604727|pmid-18285502|pmid-17599088|pmid-18285502|pmid-15035981 | It has become evident that post-transcriptional modifications of miRNAs produce multiple mature variants, which are referred to as isomiRs (26). | [
"24–28",
"13",
"26",
"29",
"26",
"30"
] | 144 | 42,804 | 1 | false | It has become evident that post-transcriptional modifications of miRNAs produce multiple mature variants, which are referred to as isomiRs. | [
"26"
] | It has become evident that post-transcriptional modifications of miRNAs produce multiple mature variants, which are referred to as isomiRs. | true | true | true | true | true | 7,418 |
4 | INTRODUCTION | 1 | 30 | [
"B24 B25 B26 B27 B28",
"B13",
"B26",
"B29",
"B26",
"B30"
] | 20,466,808 | pmid-18849523|pmid-19564845|pmid-18285502|pmid-19508715|pmid-19390579|pmid-17604727|pmid-18285502|pmid-17599088|pmid-18285502|pmid-15035981 | NGS of the small RNA transcriptome also provides data on the expression of other small RNAs, such as piRNAs, snoRNAs and other less well characterized short, regulatory RNAs that do not meet the criteria of miRNAs (30). | [
"24–28",
"13",
"26",
"29",
"26",
"30"
] | 219 | 42,805 | 1 | false | NGS of the small RNA transcriptome also provides data on the expression of other small RNAs, such as piRNAs, snoRNAs and other less well characterized short, regulatory RNAs that do not meet the criteria of miRNAs. | [
"30"
] | NGS of the small RNA transcriptome also provides data on the expression of other small RNAs, such as piRNAs, snoRNAs and other less well characterized short, regulatory RNAs that do not meet the criteria of miRNAs. | true | true | true | true | true | 7,418 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | We compared the small RNA transcriptomes of five favorable and five unfavorable, MYCN-amplified NBs by means of ultra-deep NGS using the SOLiD system (Applied Biosystems). | [
"14"
] | 171 | 42,806 | 0 | false | We compared the small RNA transcriptomes of five favorable and five unfavorable, MYCN-amplified NBs by means of ultra-deep NGS using the SOLiD system (Applied Biosystems). | [] | We compared the small RNA transcriptomes of five favorable and five unfavorable, MYCN-amplified NBs by means of ultra-deep NGS using the SOLiD system (Applied Biosystems). | true | true | true | true | true | 7,419 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | NGS results were compared with miRNA expression patterns generated for the same samples by high-throughput RT-qPCR to correlate results from both systems and validate miRNA expression patterns (14). | [
"14"
] | 198 | 42,807 | 1 | false | NGS results were compared with miRNA expression patterns generated for the same samples by high-throughput RT-qPCR to correlate results from both systems and validate miRNA expression patterns. | [
"14"
] | NGS results were compared with miRNA expression patterns generated for the same samples by high-throughput RT-qPCR to correlate results from both systems and validate miRNA expression patterns. | true | true | true | true | true | 7,419 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | Favorable and unfavorable NBs were distinguishable by hierarchical clustering of miRNA patterns. | [
"14"
] | 96 | 42,808 | 0 | false | Favorable and unfavorable NBs were distinguishable by hierarchical clustering of miRNA patterns. | [] | Favorable and unfavorable NBs were distinguishable by hierarchical clustering of miRNA patterns. | true | true | true | true | true | 7,419 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | Expression of single miRNAs also differed significantly between the two groups. | [
"14"
] | 79 | 42,809 | 0 | false | Expression of single miRNAs also differed significantly between the two groups. | [] | Expression of single miRNAs also differed significantly between the two groups. | true | true | true | true | true | 7,419 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | We subsequently analyzed RNA editing as well as occurrence and frequency of isomiR expression, and identified 13 candidates for novel miRNAs of which three were further validated in 70 primary NBs using RT-qPCR. | [
"14"
] | 211 | 42,810 | 0 | false | We subsequently analyzed RNA editing as well as occurrence and frequency of isomiR expression, and identified 13 candidates for novel miRNAs of which three were further validated in 70 primary NBs using RT-qPCR. | [] | We subsequently analyzed RNA editing as well as occurrence and frequency of isomiR expression, and identified 13 candidates for novel miRNAs of which three were further validated in 70 primary NBs using RT-qPCR. | true | true | true | true | true | 7,419 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | To our knowledge, this is the first comprehensive presentation of the composition of the small RNA transcriptome of a primary tumor, using NB as a model system. | [
"14"
] | 160 | 42,811 | 0 | false | To our knowledge, this is the first comprehensive presentation of the composition of the small RNA transcriptome of a primary tumor, using NB as a model system. | [] | To our knowledge, this is the first comprehensive presentation of the composition of the small RNA transcriptome of a primary tumor, using NB as a model system. | true | true | true | true | true | 7,419 |
5 | INTRODUCTION | 1 | 14 | [
"B14"
] | 20,466,808 | pmid-18940866 | By comparing tumors of divergent biology and clinical outcome, we also provide insights into the heterogeneity of the small RNA transcriptomes in cancer. | [
"14"
] | 153 | 42,812 | 0 | false | By comparing tumors of divergent biology and clinical outcome, we also provide insights into the heterogeneity of the small RNA transcriptomes in cancer. | [] | By comparing tumors of divergent biology and clinical outcome, we also provide insights into the heterogeneity of the small RNA transcriptomes in cancer. | true | true | true | true | true | 7,419 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B5"
] | 18,162,713 | pmid-7996359|pmid-8032367|pmid-8219187|pmid-11238097|pmid-7996359|pmid-7795648|pmid-8961624|pmid-14612666|pmid-11242115 | Wiskott-Aldrich syndrome (WAS) (Online Mendelian Inheritance in Man [OMIM] 301000) is an X-linked recessive disorder characterized by thrombocytopenia, eczema, and immunodeficiency. | [
"1",
"2",
"3",
"5"
] | 181 | 42,813 | 0 | false | Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, eczema, and immunodeficiency. | [
"Online Mendelian Inheritance in Man [OMIM] 301000"
] | Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, eczema, and immunodeficiency. | true | true | true | true | true | 7,420 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B5"
] | 18,162,713 | pmid-7996359|pmid-8032367|pmid-8219187|pmid-11238097|pmid-7996359|pmid-7795648|pmid-8961624|pmid-14612666|pmid-11242115 | Clinical symptoms include petechiae, bloody diarrhea, inability to generate antibodies against polysaccharide antigens, and in some cases, autoimmune manifestations. | [
"1",
"2",
"3",
"5"
] | 165 | 42,814 | 0 | false | Clinical symptoms include petechiae, bloody diarrhea, inability to generate antibodies against polysaccharide antigens, and in some cases, autoimmune manifestations. | [] | Clinical symptoms include petechiae, bloody diarrhea, inability to generate antibodies against polysaccharide antigens, and in some cases, autoimmune manifestations. | true | true | true | true | true | 7,420 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B5"
] | 18,162,713 | pmid-7996359|pmid-8032367|pmid-8219187|pmid-11238097|pmid-7996359|pmid-7795648|pmid-8961624|pmid-14612666|pmid-11242115 | Affected boys often die because of malignant tumors, particularly lymphoma (1, 2). | [
"1",
"2",
"3",
"5"
] | 82 | 42,815 | 0 | false | Affected boys often die because of malignant tumors, particularly lymphoma. | [
"1, 2"
] | Affected boys often die because of malignant tumors, particularly lymphoma. | true | true | true | true | true | 7,420 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B5"
] | 18,162,713 | pmid-7996359|pmid-8032367|pmid-8219187|pmid-11238097|pmid-7996359|pmid-7795648|pmid-8961624|pmid-14612666|pmid-11242115 | Treatments for WAS include antimicrobial therapy for infections, intravenous immune globulin, splenectomy for thrombocytopenia, and allogeneic bone marrow transplantation (3-5). | [
"1",
"2",
"3",
"5"
] | 177 | 42,816 | 0 | false | Treatments for WAS include antimicrobial therapy for infections, intravenous immune globulin, splenectomy for thrombocytopenia, and allogeneic bone marrow transplantation. | [
"3-5"
] | Treatments for WAS include antimicrobial therapy for infections, intravenous immune globulin, splenectomy for thrombocytopenia, and allogeneic bone marrow transplantation. | true | true | true | true | true | 7,420 |
1 | INTRODUCTION | 1 | 6 | [
"B6",
"B7",
"B8",
"B9",
"B10",
"B11"
] | 18,162,713 | pmid-8069912|pmid-8647957|pmid-7795648|pmid-8961624|pmid-14612666|pmid-11242115|NA|pmid-14612666|NA | The gene responsible for WAS was isolated, and designated the WAS gene (6). | [
"6",
"7",
"8",
"9",
"10",
"11"
] | 75 | 42,817 | 1 | false | The gene responsible for WAS was isolated, and designated the WAS gene. | [
"6"
] | The gene responsible for WAS was isolated, and designated the WAS gene. | true | true | true | true | true | 7,421 |
1 | INTRODUCTION | 1 | 6 | [
"B6",
"B7",
"B8",
"B9",
"B10",
"B11"
] | 18,162,713 | pmid-8069912|pmid-8647957|pmid-7795648|pmid-8961624|pmid-14612666|pmid-11242115|NA|pmid-14612666|NA | The gene is composed of 12 exons spanning approximately 9 kilobases. | [
"6",
"7",
"8",
"9",
"10",
"11"
] | 68 | 42,818 | 0 | false | The gene is composed of 12 exons spanning approximately 9 kilobases. | [] | The gene is composed of 12 exons spanning approximately 9 kilobases. | true | true | true | true | true | 7,421 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.